Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Archive for June, 2021

Cryoport: Strength in Stock

The meaningful increase in today’s price appears to be due to the reported approval of Gilead’s CAR-T drug Yescarta in China. On another matter, CEO Jerry Shelton (for whom I have great respect) has said that the company’s goal is to reach $650 million of sales in 2025 through organic growth.  Acquisitions could increase this. […]